Trial Profile
Comparison of teriparatide and calcitonin in the treatment of postmenopausal women with osteoporosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Calcitonin
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 24 Oct 2007 New trial record.